A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the Safety, Tolerability, PK/PD and preliminary
Efficacy of ICP-022 in Subjects with Systemic Lupus Erythematosus (SLE)